Randomized trial of radiotherapy with weekly cisplatin or cetuximab in low risk HPV associated oropharyngeal cancer (TROG 12.01): A Trans-Tasman Radiation Oncology Group study
Rischin, Danny, King, Madeleine T., Kenny, Lizbeth M., Porceddu, Sandro, Wratten, Christopher, Macann, Andrew, Jackson, James E, Bressel, Mathias, Herschtal, Alan, Richard, Fisher, Fua, Tsien, Lin, Charles, Liu, Chen-Shin, Hughes, Brett Gordon Maxwell, McGrath, Margie, McDowell, Lachlan, Corry, June
Published in Journal of clinical oncology (20.05.2021)
Published in Journal of clinical oncology (20.05.2021)
Get full text
Journal Article
DREAM3R: Durvalumab with chemotherapy as first-line treatment in advanced pleural mesothelioma—A phase 3 randomized trial
Forde, Patrick M., Nowak, Anna K., Kok, Peey-Sei, Brown, Chris, Sun, Zhuoxin, Anagnostou, Valsamo, O'Byrne, Kenneth John, Yip, Sonia, Cook, Alistair, Lesterhuis, Willem Joost, Hughes, Brett Gordon Maxwell, Pavlakis, Nick, Brahmer, Julie R., Kindler, Hedy L., Tsao, Anne S., Zauderer, Marjorie Glass, Ramalingam, Suresh S., Stockler, Martin R.
Published in Journal of clinical oncology (01.06.2022)
Published in Journal of clinical oncology (01.06.2022)
Get full text
Journal Article
Adenosine receptor blockade with ciforadenant +/- atezolizumab in advanced metastatic castration-resistant prostate cancer (mCRPC)
Harshman, Lauren Christine, Chu, Michael, George, Saby, Hughes, Brett Gordon Maxwell, Carthon, Bradley Curtis, Fong, Lawrence, Merchan, Jaime R., Kwei, Long, Hotson, Andrew N., Mobasher, Mehrdad, Miller, Richard A.
Published in Journal of clinical oncology (20.02.2020)
Published in Journal of clinical oncology (20.02.2020)
Get full text
Journal Article
KEYNOTE-629: Health-related quality of life (HRQoL) with pembrolizumab (pembro) in patients (pts) with locally advanced (LA) or recurrent or metastatic (R/M) cutaneous squamous cell carcinoma (cSCC)
Bratland, Åse, Muñoz-Couselo, Eva, Mortier, Laurent, Roshdy, Osama, Gonzalez, Rene, Schachter, Jacob, Arance, Ana Maria, Grange, Florent, Meyer, Nicolas, Joshi, Abhishek Jagdish, Billan, Salem, Hughes, Brett Gordon Maxwell, Grob, Jean-Jacques, Ramakrishnan, Karthik, Zhang, Eric (Pingye), Gumuscu, Burak, Swaby, Ramona F., Gutzmer, Ralf
Published in Journal of clinical oncology (20.05.2021)
Published in Journal of clinical oncology (20.05.2021)
Get full text
Journal Article
DREAM3R: Durvalumab with chemotherapy as first-line treatment in advanced pleural mesothelioma—A phase 3 randomized trial
Forde, Patrick M., Nowak, Anna K., Kok, Peey-Sei, Brown, Chris, Sun, Zhuoxin, Anagnostou, Valsamo, O'Byrne, Kenneth John, Yip, Sonia, Cook, Alistair, Lesterhuis, Willem Joost, Hughes, Brett Gordon Maxwell, Pavlakis, Nick, Brahmer, Julie R., Kindler, Hedy L., Tsao, Anne S., Zauderer, Marjorie Glass, Ramalingam, Suresh S., Stockler, Martin R.
Published in Journal of clinical oncology (20.05.2021)
Published in Journal of clinical oncology (20.05.2021)
Get full text
Journal Article
KEYNOTE-629: Phase 2 study of pembrolizumab for recurrent/metastatic or locally advanced unresectable cutaneous squamous cell carcinoma (cSCC)
Grob, Jean Jacques, Gonzalez, Rene, Basset-Seguin, Nicole, Schachter, Jacob, Vornicova, Olga, Bauman, Jessica Ruth, Grange, Florent, Meyer, Nicolas, Piulats, Josep M., Zhang, Eric (Pingye), Gumuscu, Burak, Swaby, Ramona F., Hughes, Brett Gordon Maxwell
Published in Journal of clinical oncology (20.05.2019)
Published in Journal of clinical oncology (20.05.2019)
Get full text
Journal Article
CCTG BR.34: A randomized trial of durvalumab and tremelimumab +/- platinum-based chemotherapy in patients with metastatic (Stage IV) squamous or nonsquamous non-small cell lung cancer (NSCLC)
Leighl, Natasha B., Laurie, Scott Andrew, Goss, Glenwood D., Hughes, Brett Gordon Maxwell, Stockler, Martin R., Tsao, Ming Sound, Kulkarni, Swati, Blais, Normand, Joy, Anil A., Mates, Mihaela, Rana, Punam, Yadav, Sunil, Underhill, Craig, Lee, Christopher W., Bradbury, Penelope Ann, Hiltz, Andrea, Dancey, Janet, Ding, Keyue, Vera Badillo, Francisco Emilio
Published in Journal of clinical oncology (20.05.2020)
Published in Journal of clinical oncology (20.05.2020)
Get full text
Journal Article
Pembrolizumab (P) or P + chemotherapy (C) versus EXTREME (E) as first-line (1L) therapy for recurrent/metastatic (R/M) head and neck squamous cell carcinoma (HNSCC): analysis of KEYNOTE-048 by disease state
Rischin, Danny, Harrington, Kevin Joseph, Greil, Richard, Soulieres, Denis, Tahara, Makoto, Castro, Gilberto, Psyrri, Amanda, Baste, Neus, Neupane, Prakash C., Bratland, Åse, Fuereder, Thorsten, Hughes, Brett Gordon Maxwell, Mesia, Ricard, Ngamphaiboon, Nuttapong, Rordorf, Tamara, Wan Ishak, Wan Zamaniah, Lin, Jianxin, Gumuscu, Burak, Swaby, Ramona F., Burtness, Barbara
Published in Journal of clinical oncology (20.05.2020)
Published in Journal of clinical oncology (20.05.2020)
Get full text
Journal Article
Phase II study of cemiplimab in patients (pts) with advanced cutaneous squamous cell carcinoma (CSCC): Longer follow-up
Rischin, Danny, Khushalani, Nikhil I., Schmults, Chrysalyne D., Guminski, Alexander David, Chang, Anne Lynn S., Lewis, Karl D., Lim, Annette May Ling, Hernandez-Aya, Leonel Fernando, Hughes, Brett Gordon Maxwell, Schadendorf, Dirk, Hauschild, Axel, Stankevich, Elizabeth, Booth, Jocelyn, Li, Siyu, Chen, Zhen, Okoye, Emmanuel, Lowy, Israel, Fury, Matthew G., Migden, Michael Robert
Published in Journal of clinical oncology (20.05.2020)
Published in Journal of clinical oncology (20.05.2020)
Get full text
Journal Article
DREAM: A phase II study of durvalumab with first line chemotherapy in mesothelioma—First results
Nowak, Anna K., Lesterhuis, Willem Joost, Hughes, Brett Gordon Maxwell, Brown, Chris, Kok, Peey Sei, O'Byrne, Kenneth John, John, Tom, Pavlakis, Nick, Kao, Steven Chuan-Hao, Yip, Sonia, Karikios, Deme John, Lam, Wei-Sen, Langford, Ailsa, Stockler, Martin R.
Published in Journal of clinical oncology (20.05.2018)
Published in Journal of clinical oncology (20.05.2018)
Get full text
Journal Article
Immune-related adverse events and nivolumab outcomes in non-small cell lung cancer patients: A multi-institutional, retrospective cohort study
Moor, Rebecca Jane, Roberts, Kate Elizabeth, Mason, Robert, Gunawan, Ben, Feng, Sophie, Hong, Jun Hee, Von Itzstein, Mitchell, Hughes, Brett Gordon Maxwell, Lwin, Zarnie, Jain, Vikram Kumar, Bigby, Kieron James, Azer, Mary W. F., Sanmugarajah, Jasotha, O'Byrne, Kenneth John
Published in Journal of clinical oncology (20.05.2018)
Published in Journal of clinical oncology (20.05.2018)
Get full text
Journal Article
Influence of tumor size and Eastern Cooperative Oncology Group performance status (ECOG PS) at baseline on patient (pt) outcomes in lenvatinib-treated radioiodine-refractory differentiated thyroid cancer (RR-DTC)
Wirth, Lori J., Leboulleux, Sophie, Kiyota, Naomi, Tahara, Makoto, Muro, Kei, Ahn, Myung-Ju, Ando, Yuichi, Taylor, Matthew H., Takahashi, Shunji, Kim, Sung-Bae, Misir, Soamnauth, Dutcus, Corina E., Xie, Ran, Joshi, Prashant Ramesh, Hughes, Brett Gordon Maxwell, Aller, Javier, Krzyzanowska, Monika K., Capdevila, Jaume
Published in Journal of clinical oncology (20.05.2019)
Published in Journal of clinical oncology (20.05.2019)
Get full text
Journal Article
Phase 2 study of cemiplimab, a human monoclonal anti-PD-1, in patients (pts) with metastatic cutaneous squamous cell carcinoma (mCSCC; Group 1): 12-month follow-up
Guminski, Alexander David, Lim, Annette May Ling, Khushalani, Nikhil I., Schmults, Chrysalyne D., Hernandez-Aya, Leonel Fernando, Modi, Badri, Dunn, Lara, Hughes, Brett Gordon Maxwell, Chang, Anne Lynn S., Hauschild, Axel, Migden, Michael Robert, Gutzmer, Ralf, Alam, Murad, Jankovic, Vladimir, Stankevich, Elizabeth, Booth, Jocelyn, Li, Siyu, Lowy, Israel, Fury, Matthew G., Rischin, Danny
Published in Journal of clinical oncology (20.05.2019)
Published in Journal of clinical oncology (20.05.2019)
Get full text
Journal Article
Development of a core outcome set for cutaneous squamous cell carcinoma trials: identification of core domains and outcomes
Reynolds, K.A., Schlessinger, D.I., Yanes, A.F., Godinez‐Puig, V., Chen, B.R., Kurta, A.O., Cotseones, J.K., Chiren, S.G., Iyengar, S., Ibrahim, S.A., Kang, B.Y., Worley, B., Behshad, R., DeHoratius, D.M., Denes, P., Drucker, A.M., Dzubow, L.M., Etzkorn, J.R., Harwood, C.A., Kim, J.Y.S., Lawrence, N., Lee, E.H., Lissner, G.S., Marghoob, A.A., Guminiski, A., Matin, R.N., Mattox, A.R., Mittal, B.B., Thomas, J.R., Zhou, X.A., Zloty, D., Hughes, B.G.M., Nottage, M.K., Green, A.C., Testori, A.A.E., Argenziano, G., Longo, C., Zalaudek, I., Lebbe, C., Malvehy, J., Saiag, P., Cernea, S.S., Schmitt, J., Kirkham, J.J., Poon, E., Sobanko, J.F., Cartee, T.V., Maher, I.A., Alam, M.
Published in British journal of dermatology (1951) (01.06.2021)
Published in British journal of dermatology (1951) (01.06.2021)
Get full text
Journal Article
Outcomes of anti-PD-1 therapy in mesothelioma and correlation with PD-L1 expression
Rivalland, Gareth, Kao, Steven Chuan-Hao, Pavlakis, Nick, Hughes, Brett Gordon Maxwell, Thapa, Bibhusal, Pal, Abhijit, Walkiewicz, Marzena, Zimet, Allan Solomon, White, Shane, O'Byrne, Ken, Mitchell, Paul, John, Thomas
Published in Journal of clinical oncology (20.05.2017)
Published in Journal of clinical oncology (20.05.2017)
Get full text
Journal Article
Association between progression-free survival (PFS) rate (PFSR) and overall survival (OS) in LUME-Meso, a study of nintedanib (N) vs. placebo (P) in combination with first-line pemetrexed/cisplatin (PEM/CIS) in patients (pts) with malignant pleural mesothelioma (MPM)
Pavlakis, Nick, Grosso, Federica, Steele, Nicola L., Nowak, Anna K., Novello, Silvia, Popat, Sanjay, Greillier, Laurent, Reck, Martin, John, Tom, Taylor, Paul, Leighl, Natasha B., Ceresoli, Giovanni Luca, Sørensen, Jens Benn, Planchard, David, Hughes, Brett Gordon Maxwell, Mazieres, Julien, Socinski, Mark A., von Wangenheim, Ute, Barrueco, Jose, Scagliotti, Giorgio V.
Published in Journal of clinical oncology (20.05.2018)
Published in Journal of clinical oncology (20.05.2018)
Get full text
Journal Article
Tumor burden (TB) and treatment exposure (TE) in patients (pts) with malignant pleural mesothelioma (MPM) receiving nintedanib (N)/placebo (P) in combination with first-line pemetrexed/cisplatin (PEM/CIS) in phase II of the LUME-Meso study
Popat, Sanjay, Grosso, Federica, Steele, Nicola, Nowak, Anna K., Novello, Silvia, Greillier, Laurent, Reck, Martin, John, Tom, Taylor, Paul, Leighl, Natasha B., Ceresoli, Giovanni Luca, Sørensen, Jens Benn, Pavlakis, Nick, Planchard, David, Hughes, Brett Gordon Maxwell, Mazieres, Julien, Socinski, Mark A., Buchner, Hannes, Barrueco, Jose, Scagliotti, Giorgio V.
Published in Journal of clinical oncology (20.05.2018)
Published in Journal of clinical oncology (20.05.2018)
Get full text
Journal Article
Primary analysis of phase 2 results for cemiplimab, a human monoclonal anti-PD-1, in patients with metastatic cutaneous squamous cell carcinoma (mCSCC)
Rischin, Danny, Migden, Michael Robert, Chang, Anne, Chung, Christine H., Dunn, Lara, Guminski, Alexander, Hauschild, Axel, Hernandez-Aya, Leonel, Hughes, Brett Gordon Maxwell, Lewis, Karl D., Lim, Annette May Ling, Modi, Badri, Schadendorf, Dirk, Schmults, Chrysalyne, Booth, Jocelyn, Li, Siyu, Mohan, Kosalai Kal, Stankevich, Elizabeth, Lowy, Israel, Fury, Matthew G.
Published in Journal of clinical oncology (20.05.2018)
Published in Journal of clinical oncology (20.05.2018)
Get full text
Journal Article
Avelumab (anti–PD-L1) in combination with crizotinib or lorlatinib in patients with previously treated advanced NSCLC: Phase 1b results from JAVELIN Lung 101
Shaw, Alice Tsang, Lee, Se-Hoon, Ramalingam, Suresh S., Bauer, Todd Michael, Boyer, Michael J., Carcereny Costa, Enric, Felip, Enriqueta, Han, Ji-Youn, Hida, Toyoaki, Hughes, Brett Gordon Maxwell, Kim, Sang-We, Nishio, Makoto, Seto, Takashi, Ezeh, Patrick, Chakrabarti, Debasis, Wang, Jing, Chang, Andrew, Fumagalli, Luca, Solomon, Benjamin J.
Published in Journal of clinical oncology (20.05.2018)
Published in Journal of clinical oncology (20.05.2018)
Get full text
Journal Article